Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit Juice
Phase 1Completed 1 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Drug Interaction
Conditions
Drug Interaction
Trial Timeline
Nov 1, 2008 → Nov 1, 2008
NCT ID
NCT00806299About Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit Juice
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit Juice is a phase 1 stage product being developed by Johnson & Johnson for Drug Interaction. The current trial status is completed. This product is registered under clinical trial identifier NCT00806299. Target conditions include Drug Interaction.
What happened to similar drugs?
8 of 15 similar drugs in Drug Interaction were approved
Approved (8) Terminated (3) Active (5)
✅Polyene phosphatidylcholine injection 930 mg QD + Magnesium Isoglycyrrhizinate injection 200 mg QDHaisco Pharmaceutical GroupApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00806299 | Phase 1 | Completed |
Competing Products
20 competing products in Drug Interaction